Seung-Yong Hwang
Directeur Technique/Scientifique/R&D chez INVITES BIOCORE CO., LTD.
Postes actifs de Seung-Yong Hwang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INVITES BIOCORE CO., LTD. | Directeur/Membre du Conseil | 01/12/2014 | - |
| Directeur Technique/Scientifique/R&D | 01/12/2014 | - | |
| Directeur Général | 01/12/2014 | - | |
| Hanyang University | Corporate Officer/Principal | 01/09/1997 | - |
Historique de carrière de Seung-Yong Hwang
Anciens postes connus de Seung-Yong Hwang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Korea Biochip Society | Corporate Officer/Principal | - | - |
| The Korean Society of Toxicogenomics & Toxicoproteomics | Corporate Officer/Principal | - | - |
GenoCheck Co., Ltd.
 GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Directeur Général | - | - |
Formation de Seung-Yong Hwang
| Monash University | Doctorate Degree |
Statistiques
Internationale
| Corée du Sud | 6 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INVITES BIOCORE CO., LTD. | Commercial Services |
| Entreprise privées | 3 |
|---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
| Korea Biochip Society | |
| The Korean Society of Toxicogenomics & Toxicoproteomics |
- Bourse
- Insiders
- Seung-Yong Hwang
- Expérience
